Sintilimab

URI: https://gptkb.org/entity/Sintilimab

GPTKB entity

Predicate	Object
gptkbp:instanceOf	gptkb:immunotherapy gptkb:monoclonal_antibody
gptkbp:administeredBy	intravenous infusion
gptkbp:approvedBy	gptkb:China
gptkbp:ATCCode	L01FF10
gptkbp:brand	gptkb:Tyvyt
gptkbp:CASNumber	1924426-52-9
gptkbp:clinicalTrialPhase	Phase III
gptkbp:developedBy	gptkb:Eli_Lilly gptkb:Innovent_Biologics
gptkbp:legalStatus	prescription only
gptkbp:macromoleculeType	gptkb:programmed_cell_death_protein_1
gptkbp:mechanismOfAction	gptkb:immunotherapy
gptkbp:routeOfAdministration	intravenous
gptkbp:target	gptkb:PD-1
gptkbp:UNII	6QX1Q21F6K
gptkbp:usedFor	gptkb:non-small_cell_lung_cancer gptkb:cancer gptkb:classical_Hodgkin_lymphoma
gptkbp:bfsParent	gptkb:Non-Small_Cell_Lung_Cancer
gptkbp:bfsLayer	6
https://www.w3.org/2000/01/rdf-schema#label	Sintilimab